Oculis (OCS) Earnings Date, Estimates & Call Transcripts → Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) (Ad) Free OCS Stock Alerts $12.07 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateSep. 3EstimatedActual EPS (Mar. 18) -$0.38 Beat By $0.04 Consensus EPS (Mar. 18) -$0.42 Get Oculis Earnings AlertsEnter your email address below to receive the latest news and earnings results for OCS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueOCS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OCS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceDoes this chart look familiar?Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here. Oculis Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.40)($0.36)($0.38)Q2 20242($0.42)($0.37)($0.40)Q3 20242($0.48)($0.35)($0.42)Q4 20242($0.44)($0.35)($0.40)FY 20248($1.74)($1.43)($1.59)OCS Earnings Date and InformationOculis last issued its earnings data on March 18th, 2024. The reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.42) by $0.04. The business earned $0.21 million during the quarter, compared to analyst estimates of $0.28 million. Oculis has generated ($1.78) earnings per share over the last year (($1.78) diluted earnings per share). Earnings for Oculis are expected to decrease in the coming year, from ($1.72) to ($2.12) per share. Oculis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 3rd, 2024 based off prior year's report dates.Read More Oculis Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 9/3/2024Estimated)------- 3/18/2024Q4 2023($0.42)($0.38)+$0.04($0.38)$0.28 million$0.21 million11/15/2023Q3 2023($0.36)($0.38)($0.02)($0.22)$0.30 million$0.25 million8/29/2023Q2 2023($0.33)($0.42)($0.09)($0.42)$0.28 million$0.28 million Oculis Earnings - Frequently Asked Questions When is Oculis's earnings date? Oculis has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 3rd, 2024 based off last year's report dates. Learn more on OCS's earnings history. Did Oculis beat their earnings estimates last quarter? In the previous quarter, Oculis (NASDAQ:OCS) reported ($0.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.42) by $0.04. Learn more on analysts' earnings estimate vs. OCS's actual earnings. How much revenue does Oculis generate each year? Oculis (NASDAQ:OCS) has a recorded annual revenue of $980,000.00. How much profit does Oculis generate each year? Oculis (NASDAQ:OCS) has a recorded net income of -$98.92 million. OCS has generated -$1.78 earnings per share over the last four quarters. What is Oculis's EPS forecast for next year? Oculis's earnings are expected to decrease from ($1.72) per share to ($2.12) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Shattuck Labs Earnings Travere Therapeutics Earnings KalVista Pharmaceuticals Earnings Altimmune Earnings Verve Therapeutics Earnings Larimar Therapeutics Earnings COMPASS Pathways Earnings Arbutus Biopharma Earnings Astria Therapeutics Earnings Applied Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:OCS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.